204 related articles for article (PubMed ID: 32488669)
1. Hyperferritinemia and acute kidney injury in pediatric patients receiving allogeneic hematopoietic cell transplantation.
Kurokawa M; Nishiyama K; Koga Y; Eguchi K; Imai T; Oba U; Shiraishi A; Nagata H; Kaku N; Ishimura M; Honjo S; Ohga S
Pediatr Nephrol; 2020 Oct; 35(10):1977-1984. PubMed ID: 32488669
[TBL] [Abstract][Full Text] [Related]
2. Pretransplant predictors and posttransplant sequels of acute kidney injury after allogeneic stem cell transplantation.
Kagoya Y; Kataoka K; Nannya Y; Kurokawa M
Biol Blood Marrow Transplant; 2011 Mar; 17(3):394-400. PubMed ID: 20655388
[TBL] [Abstract][Full Text] [Related]
3. Clinical Features of Acute Kidney Injury in the Early Post-Transplantation Period Following Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation.
Vergara-Cadavid J; Johnson PC; Kim HT; Yi A; Sise ME; Leaf DE; Hanna PE; Ho VT; Cutler CS; Antin JH; Gooptu M; Kelkar AH; Wells SL; Nikiforow S; Koreth J; Romee R; Soiffer RJ; Shapiro RM; Gupta S
Transplant Cell Ther; 2023 Jul; 29(7):455.e1-455.e9. PubMed ID: 37015320
[TBL] [Abstract][Full Text] [Related]
4. Risk Factors for Acute Kidney Injury and Chronic Kidney Disease following Allogeneic Hematopoietic Stem Cell Transplantation for Hematopoietic Malignancies.
Sakaguchi M; Nakayama K; Yamaguchi H; Mii A; Shimizu A; Inai K; Onai D; Marumo A; Omori I; Yamanaka S; Fujiwara Y; Fukunaga K; Ryotokuji T; Hirakawa T; Okabe M; Tamai H; Okamoto M; Wakita S; Yui S; Tsuruoka S; Inokuchi K
Acta Haematol; 2020; 143(5):452-464. PubMed ID: 31822013
[TBL] [Abstract][Full Text] [Related]
5. Acute Kidney Injury in Pediatric Patients Receiving Allogeneic Hematopoietic Cell Transplantation: Incidence, Risk Factors, and Outcomes.
Koh KN; Sunkara A; Kang G; Sooter A; Mulrooney DA; Triplett B; Onder AM; Bissler J; Cunningham LC
Biol Blood Marrow Transplant; 2018 Apr; 24(4):758-764. PubMed ID: 29196074
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for acute kidney injury in patients undergoing allogeneic hematopoietic stem cell transplantation.
Yu ZP; Ding JH; Chen BA; Liu BC; Liu H; Li YF; Ding BH; Qian J
Chin J Cancer; 2010 Nov; 29(11):946-51. PubMed ID: 20979694
[TBL] [Abstract][Full Text] [Related]
7. Acute Kidney Injury and the Risk of Mortality in Children Undergoing Hematopoietic Stem Cell Transplantation.
Kizilbash SJ; Kashtan CE; Chavers BM; Cao Q; Smith AR
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1264-1270. PubMed ID: 27034153
[TBL] [Abstract][Full Text] [Related]
8. Comparison of ARF after myeloablative and nonmyeloablative hematopoietic cell transplantation.
Parikh CR; Schrier RW; Storer B; Diaconescu R; Sorror ML; Maris MB; Maloney DG; McSweeney P; Storb R; Sandmaier BM
Am J Kidney Dis; 2005 Mar; 45(3):502-9. PubMed ID: 15754272
[TBL] [Abstract][Full Text] [Related]
9. Acute Kidney Injury in the Modern Era of Allogeneic Hematopoietic Stem Cell Transplantation.
Abramson MH; Gutgarts V; Zheng J; Maloy MA; Ruiz JD; Scordo M; Jaimes EA; Sathick IJ
Clin J Am Soc Nephrol; 2021 Sep; 16(9):1318-1327. PubMed ID: 34135023
[TBL] [Abstract][Full Text] [Related]
10. Impact of hyperferritinemia on the outcome of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for lymphoid malignancies.
Barba P; Valcárcel D; Pérez-Simón JA; Fernández-Avilés F; Piñana JL; Martino R; López-Anglada L; Rovira M; Garcia-Cadenas I; Novelli S; Carreras E; López Corral L; Sierra J
Biol Blood Marrow Transplant; 2013 Apr; 19(4):597-601. PubMed ID: 23305680
[TBL] [Abstract][Full Text] [Related]
11. Risk assessment for acute kidney injury after allogeneic hematopoietic stem cell transplantation based on Acute Kidney Injury Network criteria.
Mori J; Ohashi K; Yamaguchi T; Ando M; Hirashima Y; Kobayashi T; Kakihana K; Sakamaki H
Intern Med; 2012; 51(16):2105-10. PubMed ID: 22892486
[TBL] [Abstract][Full Text] [Related]
12. Independent risk factors and long-term outcomes for acute kidney injury in pediatric patients undergoing hematopoietic stem cell transplantation: a retrospective cohort study.
Hirano D; Kakegawa D; Miwa S; Umeda C; Takemasa Y; Tokunaga A; Kawakami Y; Ito A
BMC Nephrol; 2020 Aug; 21(1):373. PubMed ID: 32854640
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after Second Hematopoietic Stem Cell Transplantations in Pediatric Patients with Relapsed Hematological Malignancies.
Naik S; Martinez C; Leung K; Sasa G; Nguyen NY; Wu MF; Gottschalk S; Brenner M; Heslop H; Krance R
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1266-72. PubMed ID: 25765555
[TBL] [Abstract][Full Text] [Related]
14. Post-transplant ferritin level predicts outcomes after allogeneic hematopoietic stem cell transplant, independent from pre-transplant ferritin level.
Fingrut W; Law A; Lam W; Michelis FV; Viswabandya A; Lipton JH; Kumar R; Mattsson J; Kim DDH
Ann Hematol; 2021 Mar; 100(3):789-798. PubMed ID: 33415423
[TBL] [Abstract][Full Text] [Related]
15. Urinary elafin and kidney injury in hematopoietic cell transplant recipients.
Hingorani S; Finn LS; Pao E; Lawler R; Schoch G; McDonald GB; Najafian B; Sandmaier B; Gooley T
Clin J Am Soc Nephrol; 2015 Jan; 10(1):12-20. PubMed ID: 25388519
[TBL] [Abstract][Full Text] [Related]
16. Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation.
Al-Hazzouri A; Cao Q; Burns LJ; Weisdorf DJ; Majhail NS
Biol Blood Marrow Transplant; 2008 Jun; 14(6):658-63. PubMed ID: 18489991
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for acute kidney injury in pediatric patients after hematopoietic stem cell transplantation: a systematic review and meta-analysis.
Huang B; Shan J; Yi L; Xin Y; Zhong Z; Xu H
Pediatr Nephrol; 2024 Feb; 39(2):397-408. PubMed ID: 37079103
[TBL] [Abstract][Full Text] [Related]
18. An evaluation of the RIFLE criteria for acute kidney injury after myeloablative allogeneic haematopoietic stem cell transplantation.
Bao YS; Xie RJ; Wang M; Feng SZ; Han MZ
Swiss Med Wkly; 2011; 141():w13225. PubMed ID: 21769755
[TBL] [Abstract][Full Text] [Related]
19. Survival and Late Effects after Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancy at Less than Three Years of Age.
Vrooman LM; Millard HR; Brazauskas R; Majhail NS; Battiwalla M; Flowers ME; Savani BN; Akpek G; Aljurf M; Bajwa R; Baker KS; Beitinjaneh A; Bitan M; Buchbinder D; Chow E; Dandoy C; Dietz AC; Diller L; Gale RP; Hashmi SK; Hayashi RJ; Hematti P; Kamble RT; Kasow KA; Kletzel M; Lazarus HM; Malone AK; Marks DI; O'Brien TA; Olsson RF; Ringden O; Seo S; Steinberg A; Yu LC; Warwick A; Shaw B; Duncan C
Biol Blood Marrow Transplant; 2017 Aug; 23(8):1327-1334. PubMed ID: 28461213
[TBL] [Abstract][Full Text] [Related]
20. Association of Chronic Graft-versus-Host Disease with Late Effects following Allogeneic Hematopoietic Cell Transplantation for Children with Hematologic Malignancy.
Lee CJ; Wang T; Chen K; Arora M; Brazauskas R; Spellman SR; Kitko C; MacMillan ML; Pidala JA; Auletta JJ; Badawy SM; Bhatt N; Bhatt VR; Cahn JY; DeFilipp Z; Diaz MA; Farhadfar N; Gadalla S; Gale RP; Hashem H; Hashmi S; Hematti P; Hong S; Hossain NM; Inamoto Y; Lekakis LJ; Modi D; Patel S; Sharma A; Solomon S; Couriel DR
Transplant Cell Ther; 2022 Oct; 28(10):712.e1-712.e8. PubMed ID: 35863740
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
